Research Solutions Q3 revenue $12.1M (+17% YoY); ARR $16.6M (+82%); adjusted EBITDA record $961K

Research Solutions, Inc.

2024-Q3 EPS reported -$0.03 revenue$32,490,385

Total revenue $12.1M, up 17% YoY; platform revenue $4.0M (+76% YoY).
ARR grew 82% to $16.6M, with B2B ARR $11.7M and B2C ARR $4.9M.
Net income $76K ($0.00 EPS) vs $237K ($0.01) prior; adjusted EBITDA record $961K vs $559K.
Gross margin improved 630 bps to 45.2%; operating cash flow record over $2M.
Launched two new product offerings: Technology Landscape and Clinical Trial Landscape.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Research Solutions, Inc. reported third quarter ended March 31, 2024 results: revenue $12.1 million, net income $76,000, EPS $0.00 per diluted share.

Period: third quarter ended March 31, 2024
Revenue: $12.1 million
Net income: $76,000
EPS: $0.00 per diluted share
Result: reported results

Exact text from the filing

reported financial results for its fiscal third quarter ended March 31, 2024. Fiscal Third Quarter 2024 Summary (compared to prior-year quarter) · Total revenue of $12.1 million, a 17% increase. · Platform revenue up 76% to $4.0 million. Annual Recurring Revenue (“ARR”) up 82% to $16.6 million, which includes approximately $11.7 million of B2B

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Research Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-059331

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.